Nivalis Therapeutics (NVLS) Surges Ahead of Tomorrow's Conference Presentation
- Wall St. opens higher as M&A activity boosts confidence
- AT&T (T) to Acquire Time Warner (TWX) for $107.50/Share
- Rockwell Collins (COL) to Acquire B/E Aerospace (BEAV) for $6.4B
- TD Ameritrade (AMTD) to Acquire Scottrade in $4B Cash & Stock Deal
- Pre-Open Stock Movers 10/24: (BEAV) (JPEP) (HLT) Higher; (BAS) (INO) (ADRO) Lower (more...)
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Nivalis Therapeutics (NASDAQ: NVLS) is seeing strong upside ahead of tomorrow's Baird healthcare conference. Shares are up 18.4% on volume that is running 6x the norm.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Aduro Biotech (ADRO), Inovio Pharma (INO), and Merchants Bancshares (MBVT) trading halted with news pending
- Time Warner (TWX) volatility elevated into AT&T (T) deal
- AT&T (T) volatility up into buyout of Time Warner (TWX)
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Related EntitiesRobert W Baird
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!